Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

84results about How to "Delay progress" patented technology

Multi-dimensional evaluation system for senile weakness and Parkinson's disease based on intelligent single-chip microcomputer

The invention discloses a senile weakness and Parkinson's disease multi-dimensional evaluation system based on an intelligent single-chip microcomputer, and belongs to the technical field of disease evaluation. The senile weakness and Parkinson's disease multi-dimensional evaluation system comprises a data acquisition module used for acquiring patient multi-dimensional real-time data based on artificial intelligence; the data transmission module is used for uploading the multi-dimensional real-time data of the patient based on artificial intelligence to the multi-dimensional evaluation terminal; and the multi-dimensional evaluation terminal is used for processing, analyzing and evaluating the multi-dimensional real-time data of the patient based on artificial intelligence, and determining a multi-dimensional evaluation result of senile weakness and Parkinson's disease based on the intelligent single-chip microcomputer. The problems that real-time monitoring and multi-dimensional evaluation cannot be carried out on senile weakness and Parkinson's disease based on an intelligent single-chip microcomputer in the prior art, and disease deterioration cannot be effectively prevented are solved. Real-time monitoring and multi-dimensional evaluation can be performed on senile weakness and Parkinson's disease on the basis of the intelligent single chip microcomputer, the illness state of a patient can be mastered in time, the patient can be tracked and treated in time, disease progression is slowed down, and deterioration of the illness state can be effectively prevented.
Owner:SECOND MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL

Parkinson's disease early diagnosis system based on eyeball movement characteristic analysis

The invention discloses a Parkinson's disease early diagnosis system based on eyeball movement characteristic analysis, and relates to the technical field of Parkinson's disease diagnosis. In order to solve the problems that although eye and face movement parameters possibly change in Parkinson's disease, the change of the parameters also possibly occurs in other neurodegenerative diseases or normal aging processes, and high-precision eye and face movement capture data is complex, so that early diagnosis characteristics of Parkinson's disease cannot be accurately captured, and the Parkinson's disease cannot be accurately diagnosed. And the accuracy and efficiency of diagnosis are influenced. By accurately capturing and analyzing eyeball movement data and facial expression video images of a patient, the Parkinson's disease can be effectively distinguished from other diseases possibly causing similar symptoms, misdiagnosis and missed diagnosis are reduced, the standardization and comparability of data are ensured by combining pupil distance information and diopter information, the consistency and reliability of diagnosis are improved, and the diagnosis accuracy is improved. Therefore, the patient can be diagnosed at the early stage of the disease and is treated as soon as possible, and the treatment effect and life quality are improved.
Owner:SECOND MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL

Application of plasma-derived exosome in preparation of medicine for improving or treating oral diseases

The invention discloses an application of a plasma-derived exosome in preparation of a medicine for improving or treating oral diseases. The plasma-derived exosome has good biological effects of inhibiting inflammation, promoting angiogenesis and accelerating lesion healing, and the healing of mucosal injury is accelerated by inhibiting the release of inflammatory factors and chemotactic factors, so that the progress of inflammation is reduced. In addition, the plasma-derived exosome can promote human oral epithelial cell proliferation and scratch healing, and has a good effect in the aspect of improving oral diseases.
Owner:SHANDONG QILU STEM CELL ENG +1

CD33 blocking antibody and application

ActiveCN119241711AIt has a specific blocking effecthigh affinityDigestive systemAntibody ingredients
The invention discloses a CD33 blocking antibody, which is HZAB1 or HZAB2, and also discloses a CD33 blocking antibody. The amino acid sequence of the HZAB1 heavy chain variable region is as shown in SEQ ID NO. 1; the amino acid sequence of the HZAB1 light chain variable region is as shown in SEQ ID NO. 2; the amino acid sequence of the HZAB2 heavy chain variable region is as shown in SEQ ID NO. 3; and the amino acid sequence of the HZAB2 light chain variable region is as shown in SEQ ID NO. 4. The HZAB1 and HZAB2 antibodies can improve the phagocytic efficiency of macrophages on colorectal neuroendocrine cancer cells and small cell lung cancer cells, and slow down the progress of colorectal neuroendocrine cancer and small cell lung cancer.
Owner:RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

A CD33 blocking antibody and its application

ActiveCN119241711BIt has a specific blocking effecthigh affinityDigestive systemAntibody ingredients
The present invention discloses a CD33 blocking antibody, which is HZAB_1 or HZAB_2; the amino acid sequence of the heavy chain variable region of HZAB_1 is shown in SEQ ID NO.1; the amino acid sequence of the light chain variable region of HZAB_1 is shown in SEQ ID NO.2; the amino acid sequence of the heavy chain variable region of HZAB_2 is shown in SEQ ID NO.3; the amino acid sequence of the light chain variable region of HZAB_2 is shown in SEQ ID NO.4. HZAB_1 and HZAB_2 antibodies can improve the phagocytic efficiency of macrophages on colorectal neuroendocrine cancer cells and small cell lung cancer cells, and slow down the progression of colorectal neuroendocrine cancer and small cell lung cancer.
Owner:RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Monoclonal antibody 6G2 for resisting DENV NS1 protein as well as preparation method and application of monoclonal antibody 6G2

The invention provides a monoclonal antibody 6G2 resisting DENV NS1 protein and application of the monoclonal antibody 6G2. The CDR amino acid sequence of a heavy chain of the monoclonal antibody 6G2 resisting the DENV NS1 protein is shown as SEQ ID No.1, and the CDR amino acid sequence of a light chain of the monoclonal antibody 6G2 resisting the DENV NS1 protein is shown as SEQ ID No.3. The invention also provides application of the monoclonal antibody 6G2 to preparation of drugs for treating dengue virus infection, and the monoclonal antibody 6G2 for resisting DENV NS1 protein has the performances of competitively binding DENV1-4NS1 protein, inhibiting vascular leakage symptoms and protecting DENV infected fatal injury in vivo, and has potential important value for treating severe dengue fever. The monoclonal antibody 6G2 developed by the invention has important significance and application potential for prevention and treatment of dengue virus infection, including severe dengue fever.
Owner:SOUTHERN MEDICAL UNIVERSITY

Intelligent lavage and drainage system for gastrointestinal surgery

The invention discloses an intelligent lavage and drainage system for gastrointestinal surgery in the technical field of gastrointestinal surgery, and the system comprises an information collection module which is used for collecting gastrointestinal pressure information of a patient and recording and storing the pressure information; the data analysis and processing module is used for establishing a pressure model and a pressure threshold value by utilizing a machine learning algorithm based on the collected pressure information; the intelligent control module is used for controlling the flow speed and flow of the lavage fluid and the drainage fluid in different time periods according to the pressure information; and the early warning module is used for monitoring abnormal conditions of the gastrointestinal tract, automatically starting a drainage function and sending out an alarm signal when monitoring that the pressure information exceeds a preset pressure threshold value. By analyzing the relevance between various characteristic information and gastrointestinal tract environment information of the patient, the lavage and drainage parameters are automatically adjusted according to individual differences of the patient, and a more personalized treatment scheme can be provided, so that the treatment effect is improved.
Owner:JIANGYIN PEOPLES HOSPITAL

Nicotinamide for the treatment and prevention of ocular neurodegenerative diseases such as glaucoma

The present invention relates to the use of pharmaceutical compositions comprising nicotinamide (NAM) and / or pyruvic acid as neuroprotective drugs or gene therapy in the treatment of axonal degeneration of neuronal tissue in neurodegenerative disorders, particularly eye-related neurodegenerative diseases, including glaucoma.
Owner:JACKSON LAB THE

Aggregate of matrix-enabled mesenchymal stem cells and application thereof

The invention relates to the technical field of biology, in particular to a matrix-enabled mesenchymal stem cell aggregate and application, and the matrix-enabled mesenchymal stem cell aggregate is obtained by subculturing matrix-enabled mesenchymal stem cells in a 3D cell culture system. The matrix-enabled mesenchymal stem cells are obtained by subculture of mesenchymal stem cells in a cell culture matrix, and the cell culture matrix is prepared from 1-3 parts of hE-cad-Fc and 1-3 parts of hN-cad-Fc. Endogenous epithelium cadherin and nerve cadherin are highly expressed in cell aggregation cells, so that transcription factors are promoted to enter nuclei, the expression levels of anti-inflammatory immune regulation related factors and matrix degradation and cell migration related factors are up-regulated, and activated macrophages are promoted to be polarized to M2 type macrophages; the effects of anti-inflammation, immune regulation, tissue damage repair and the like of intravenous implantation of the matrix-enabled mesenchymal stem cell aggregate for treating diseases such as hepatic fibrosis, diabetes mellitus, nerve injury and the like are remarkably improved.
Owner:NANKAI UNIV

Atherosclerosis excision device

The invention belongs to the technical field of medical instruments, and particularly relates to an atherosclerosis resection device which comprises a puncture cannula, a shell is in threaded connection with the interior of the puncture cannula, a connecting pipe A is fixedly connected to one end of the shell, and a hole fixedly connected with the cannula is formed in the outer surface of the connecting pipe A; the interior of the sleeve is in threaded connection with a collecting component, and one end of the connecting pipe A is fixedly connected with a connecting pipe B; by means of the collecting component arranged in cooperation with the structure, after the artery plaque is cut up, the artery plaque needs to be removed from the blood vessel, after being removed, the artery plaque is placed in the collecting component, and assemblies in the collecting component can filter the artery plaque and conduct dry-wet separation; the separated artery plaque can be subjected to more detailed pathological and biochemical analysis, composition and characteristics of the plaque can be known, and damage to surrounding tissues in the operation process can be reduced by grinding the plaque and collecting the plaque in a sealed mode.
Owner:NANJING DRUM TOWER HOSPITAL +1

Pirfenidone solution for inhalation and use method thereof

The invention discloses a pirfenidone solution for inhalation and a use method thereof, and belongs to the technical field of pulmonary fibrosis, the pirfenidone solution is prepared from the following raw materials in parts by weight: pirfenidone and an isotonic agent in a mass ratio of (10-50): 28, during preparation, a dissolving agent accounting for 80% of the dosage of the pirfenidone and the isotonic agent is measured, the solution temperature is controlled to be 40 DEG C, the solution preparation time is 60 min, the volume is fixed to 4 mL, and the solution is prepared into the solution. And filtering the solution through a polyether filter membrane, and filling into an ampoule bottle. The invention relates to a pirfenidone solution for inhalation and a use method thereof, and solves the technical problem that in the prior art, the gastrointestinal tract effect and hepatotoxicity of pirfenidone are obvious when the pirfenidone is orally taken.
Owner:YANBIAN UNIV

TRNA derivative fragment and application thereof

The invention discloses a tRNA (transfer ribonucleic acid) derivative fragment and provides a potential functional application of the tRNA derivative fragment in DKD. And a tRNA derivative fragment, the tRNA derivative fragment is tRF3-IleAAT, and the nucleotide sequence of the tRNA derivative fragment is SEQ ID No. 1. The invention discloses an application of tRF3-IleAAT in preparation of a medicine for treating diabetic nephropathy and an application of a preparation for detecting the expression quantity of tRNA derived fragments in preparation of a diagnostic reagent for diagnosing diabetic nephropathy. According to the research, a new insight is provided for the molecular mechanism of the DKD from the perspective of tRFs and ferroptosis deposition, and a theoretical basis is provided for clinical diagnosis and treatment of the DKD.
Owner:NANJING PUKOU HOSPITAL

Application of a reagent for detecting retinol metabolites in preparing a tool for diagnosing and / or treating pneumoconiosis

The present invention provides an application of a reagent for detecting retinol metabolites in the preparation of a tool for diagnosing and / or treating pneumoconiosis, and relates to the field of biomedical technology. The present invention verifies that retinol metabolism disorders and all-trans retinoic acid deficiency are closely related to the occurrence of pneumoconiosis, and therefore proposes to use retinol and all-trans retinoic acid as biomarkers for screening pneumoconiosis and apply them to the preparation of related products for diagnosing pneumoconiosis; at the same time, all-trans retinoic acid intervention for pneumoconiosis can effectively slow down the progression of pneumoconiosis, and therefore proposes for the first time to use all-trans retinoic acid as a drug for treating pneumoconiosis.
Owner:INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES

Use of an agent that inhibits expression of an ADNP gene or activity of an ADNP protein in the preparation of a medicament for treating renal fibrosis

PendingCN122272813AInhibit expressionReliable intervention targetsPharmaceutical drugRenal Tubular Epithelial Cells
This invention discloses the application of a reagent that inhibits ADNP gene expression or ADNP protein activity in the preparation of drugs for treating renal fibrosis, belonging to the field of biomedical technology. The application of the reagent that inhibits ADNP gene expression or ADNP protein activity in the preparation of drugs for treating renal fibrosis. This invention effectively knocks down or knocks out the ADNP gene in renal tubular epithelial cells, objectively investigates the effects of ADNP deficiency on a series of phenotypes in HK-2 cells, and confirms that ADNP can inhibit EMT and renal fibrosis in HK-2 cells. Drugs that target and knock down or knock out the ADNP gene in human kidneys can be developed to delay the progression of renal fibrosis.
Owner:THE SEVENTH MEDICAL CENTER OF PLA GENERAL HOSPITAL

Use of dronedarone hydrochloride in the preparation of a medicament for the treatment of non-alcoholic fatty liver disease and cholestatic liver disease

The application relates to the field of biological medicine, and provides application of hydrochloric acid dinedarong in preparation of a medicine for treating non-alcoholic fatty liver disease and cholestatic liver disease. The application discloses a new medical use of hydrochloric acid dinedarong, which can significantly reduce liver injury, lipid deposition in the liver and liver fibrosis caused by high-fat high-fructose high-cholesterol diet, and can reduce liver injury and liver fibrosis caused by cholestasis. Therefore, the hydrochloric acid dinedarong has the effect of treating non-alcoholic fatty liver disease and cholestatic liver disease.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV

An alzheimer's disease prediction method, system, device, and medium

This invention relates to the field of medical data processing technology, and discloses an Alzheimer's disease prediction method, system, device, and medium, comprising: obtaining spectral data of a target group in a non-invasive manner; training an Alzheimer's disease prediction model based on the spectral data; the target group includes healthy individuals and individuals with Alzheimer's disease. This invention non-invasively obtains samples from the target group, utilizing the advantages of laser-induced breakdown spectroscopy (LAS) for simultaneous detection and analysis of all elements at high speed. It achieves qualitative or quantitative analysis of the chemical composition of material surfaces by measuring the emission spectrum of micro-plasma, accurately and rapidly obtaining spectral data of the target group. The Alzheimer's disease prediction model trained based on the spectral data can effectively assist doctors in early screening of individuals, enabling early intervention for patients with early-stage Alzheimer's disease, and has broad application prospects.
Owner:INST OF MODERN PHYSICS CHINESE ACADEMY OF SCI

Application of mitoxantrone preparation in preparation of drug for diagnosing and treating disease related to thyroidectomy

An application of a mitoxantrone preparation in preparation of a drug for diagnosing and treating a disease related to thyroidectomy, and use of mitoxantrone and / or a pharmaceutically acceptable salt thereof in preparation of a lymph tracer for preventing parathyroid gland staining in error, preventing parathyroid gland cutting in error, or reducing the rate of parathyroid gland cutting in error. Local injection of a mitoxantrone hydrochloride injection fluid would not cause parathyroid gland staining in error, and can reduce the rate of parathyroid gland cutting in error, thus protecting parathyroid glands well; moreover, no local or systemic toxic side effect is found after the local injection. The present invention has good tolerability, efficacy, and safety, and provides a new treatment idea in radically curing thyroid diseases thoroughly for patients suffering from diseases related to thyroidectomy.
Owner:SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL & PHARMA CO LTD +1

Traditional Chinese medicine composition for treating primary sicca syndrome complicated with interstitial lung disease and application thereof

The invention provides a traditional Chinese medicine composition for treating primary sicca syndrome complicated with interstitial lung disease and application of the traditional Chinese medicine composition, and relates to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 10-15g of radix glehniae, 10-15g of radix ophiopogonis, 15-30g of radix pseudostellariae, 10-20g of curcuma zedoary, 6-12g of roasted stiff silkworm and 15-30g of wild buckwheat rhizome. The traditional Chinese medicine composition can safely and effectively improve the respiratory function, dry mouth, dry eye and other symptoms of pSS-ILD patients, improve the life quality of the patients and delay the disease progression, has no obvious side effect, and is simple in formula and low in cost.
Owner:NANJING UNIV OF TRADITIONAL CHINESE MEDICINE

Traditional Chinese medicine composition for preventing and treating ocular surface injury caused by xerophthalmia and application of traditional Chinese medicine composition

The invention relates to a traditional Chinese medicine composition for preventing and treating ocular surface injury caused by xerophthalmia and application thereof. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 20-40 parts of spica prunellae, 20-40 parts of radix astragali, 5-25 parts of rhizoma polygonati, 5-25 parts of folium mori and 5-25 parts of fructus crataegi. Compared with the prior art, the traditional Chinese medicine composition disclosed by the invention consists of five medicinal and edible Chinese herbal medicines, is simple and convenient to take, safe and free from side effects, and can be popularized and used as a medicine for preventing and treating xerophthalmia. The traditional Chinese medicine composition disclosed by the invention can be used for remarkably inhibiting the corneal injury related to the xerophthalmia, maintaining the number of conjunctival goblet cells and providing new treatment for relieving the ocular surface injury of the xerophthalmia.
Owner:YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE

Compound for treating osteoarthritis and application thereof

The invention belongs to the technical field of medicine, and discloses a compound for treating osteoarthritis and application thereof, the compound is named as 3, 8-dihydroxy-9-methyl-2-fenchene, and the molecular formula is C11H18O2. According to the application of the 3, 8-dihydroxy-9-methyl-2-fenchene disclosed by the invention, the 3, 8-dihydroxy-9-methyl-2-fenchene is used for preparing the medicine for treating osteoarthritis. The medicine for treating osteoarthritis is a tablet, an injection or a capsule.
Owner:FIRST AFFILIATED HOSPITAL OF GANNAN MEDICAL UNIV +1

Composition for treating brain injury and neurodegenerative disease and application thereof

The invention relates to the technical field of neurology, in particular to a composition for treating brain injury and neurodegenerative lesion and application thereof, the composition is composed of an antioxidant and an anti-inflammatory drug, the antioxidant comprises vitamins, flavonoids, polysaccharides, saponins and active peptides according to the mass ratio of 4: 3: 1: 4: 2, and the content of the antioxidant is 60-80 parts; the anti-inflammatory drug comprises a non-steroidal anti-inflammatory drug NSAIDs, and the number of the components of the anti-inflammatory drug is 20-40 parts. By utilizing the synergistic effect of various active ingredients, the traditional Chinese medicine composition can comprehensively improve the symptoms of a patient, relieve pain, improve sleep and improve the cognitive function, thereby delaying neurodegenerative diseases and being beneficial to improving the functional state of neurons.
Owner:陈琨

Use of NLN neurolysin in the preparation of drugs for treating lung cancer

The present invention provides a use of NLN neurolysin in preparing a drug for preventing and treating lung cancer, and the present invention belongs to the field of medical science. It is first found that the level of NLN neurolysin in lung cancer tissue of lung cancer patients is significantly higher than that in adjacent cancer tissue. The present invention verifies that knocking out the NLN neurolysin gene can effectively prevent and treat lung cancer through gene knockout, and the present invention provides a target and treatment strategy for clinical treatment of lung cancer.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Novel therapeutic target PRMT3 for Tau proteopathy

The invention discloses a novel Tau proteopathy treatment target PRMT3, and relates to the technical field of Tau proteopathy treatment, the key points of the technical scheme are as follows: the target PRMT3 is used for promoting asymmetric dimethylation of histone H4R3, and the action flow of the target PRMT3 is as follows: methylated H4R3me2a is combined with a promoter region of miR-448 to promote transcription of miR-448, so that the target PRMT3 is obtained. Meanwhile, excessive miR-448 is combined with mRNA of IGF1R through complementary base pairing, so that the mRNA of the IGF1R is degraded, a PI3K / AKT / GSK3beta signal axis is further inhibited, and the phosphorylation level of Tau is promoted. According to the application, PRMT3 is taken as a therapeutic target, Tau pathological changes can be effectively relieved by knocking down the expression level of PRMT3 or using an inhibitor to reduce the activity of PRMT3 protein, and the neuronal function and the cognitive function are improved.
Owner:INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES

Application of breast milk oligosaccharide in preparation of preparation for inhibiting proliferation of intestinal tract Ruminococcus

The invention relates to an application of breast milk oligosaccharide in preparation of a preparation for inhibiting proliferation of intestinal tract Ruminococcus, the breast milk oligosaccharide is 2 '-FL and / or 6'-SL, the relative abundance of the intestinal tract Ruminococcus can be obviously reduced, the proliferation of the intestinal tract Ruminococcus can be inhibited, and the breast milk oligosaccharide can be applied to preparation of the preparation for inhibiting the proliferation of the intestinal tract Ruminococcus. The breast milk oligosaccharide is 2 '-FL or a composition of 2'-FL and 6 '-SL, compared with 2'-FL or a composition of 2 '-FL and 6'-SL, the breast milk oligosaccharide has a better inhibition effect on intestinal tract Ruminococcus, can be applied to preparation of a preparation for inhibiting abnormal proliferation of intestinal tract Ruminococcus of a patient suffering from the inflammatory bowel disease, and is particularly applied to preparation of a preparation for preventing enteritis and maintaining intestinal health.
Owner:CABIO BIOTECH (WUHAN) CO LTD

Application of GPR55 antagonist CID16020046 in treatment of diabetic nephropathy

The invention belongs to the technical field of biomedicine, and particularly relates to application of a GPR55 antagonist CID16020046 in treatment of diabetic nephropathy. In order to clinically select small-molecule targeted drugs for intervention and treatment of diabetic nephropathy, the invention discloses the treatment effect of the GPR55 antagonist CID16020046 on diabetic nephropathy, and the GPR55 antagonist CID16020046 can improve renal functions, relieve histological changes of kidneys, resist renal fibrosis and play a role in protecting renal tubule injuries caused by diabetic nephropathy.
Owner:SHANXI MEDICAL UNIV

Application of MYC mRNA translation inhibitor in preparation of medicine for preventing and / or treating osteoarthritis

PendingCN121971624AEffectively regulate abnormal activation statusreduce degradationOrganic active ingredientsAntipyreticPharmaceutical drugMyc proteins
The invention belongs to the technical field of biological medicines, and particularly relates to application of an MYC mRNA translation inhibitor in preparation of a medicine for preventing and / or treating osteoarthritis. The MYC mRNA translation inhibitor is selected from biological materials capable of inhibiting or blocking the MYC mRNA translation process, reducing the MYC protein synthesis efficiency or interfering the MYC mRNA steady state level. The invention provides a novel molecular target capable of being used for treating osteoarthritis and a medicine application scheme of the molecular target.
Owner:NANCHANG UNIV

Use of small molecule compound LZ-09 in the preparation of a drug for treating and / or preventing multiple sclerosis

ActiveCN116139150Breduce vitalityReduce neurological deficit symptom scoresStainingSpinal cord
The present application relates to the technical field of medicine, especially relates to application of a small molecule compound LZ-09 in preparation of a medicine for treating and / or preventing multiple sclerosis. The present application adopts H2O2 damage OLN-93 cells as a nerve cell oxidative stress model, and the result shows that LZ-09 treatment significantly weakens the cell viability decrease caused by H2O2. The classic EAE model is made by using MOG35-55 to induce C57BL / 6 mice, and it is found that after LZ-09 intervention, the mouse neurological deficit symptom score is significantly reduced, and the disease progression is delayed, and spinal cord tissue HE and LFB staining find that the inflammation infiltration and demyelination are reduced. Therefore, the compound can effectively alleviate the symptoms of multiple sclerosis, can be used as a medicine for treating multiple sclerosis, and has wide development and application prospect.
Owner:YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE

Rare earth metal powder explosion-proof dust collecting device

The utility model relates to rare earth hydrogen storage alloy or quick -setting neodymium iron boron alloy smelting auxiliary equipment technical field, specific, relate to a kind of rare earth metal powder explosion -proof dust collecting device, including shell, filter bag chamber, backflush mechanism, dust-containing gas inlet, purified gas outlet, still include inert gas supply gas path, explosion suppressor, explosion vent. Nitrogen gas path is introduced on the one hand reduces the oxygen content in dust collecting device, makes oxygen concentration reduce, reduces the oxidation reaction of rare earth metal, reduces the generation of heat. On the other hand, nitrogen in nitrogen gas path low pressure gas path is obtained by high-pressure liquid nitrogen throttling pressure reduction, temperature is lower, it is favorable to reduce the temperature in dust collecting device. The introduction of nitrogen gas path greatly reduces the explosion risk, this is the conventional working process. By introducing explosion suppressor, explosion vent, cooling can be carried out when temperature is too high and pressure relief after explosion, to slow down the progress of explosion and protect the entire device after explosion.
Owner:ZHONGXIN (WEISHAN) RARE EARTH NEW MATERIALS CO LTD

Traditional Chinese medicine composition for treating AIDS and preparation method thereof

The invention aims to provide a traditional Chinese medicine composition for treating AIDS (Acquired Immune Deficiency Syndrome). The pharmaceutical composition is prepared by processing the following raw material medicines: astragalus membranaceus, codonopsis pilosula, radix scrophulariae, bran-fried rhizoma atractylodis macrocephalae, Chinese yam, pericarpium citri reticulatae, angelica sinensis, salvia miltiorrhiza, ligusticum wallichii, radix cyathulae, raw liquorice, scorched hawthorn fruit, scorched medicated leaven and scorched malt. Pharmacodynamic tests prove that the medicine can enhance the immune function of AIDS patients, delay the decline speed of CD4 + T cells, activate latent HIV viruses and reservoirs, slow down the disease progress, protect the liver function, relieve clinical symptoms and the like.
Owner:BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV